| 1 |
Yan H, Kawano T, Kanki H, Nishiyama K, Shimamura M, Mochizuki H, Sasaki T. Role of Polymorphonuclear Myeloid-Derived Suppressor Cells and Neutrophils in Ischemic Stroke. J Am Heart Assoc 2023;12:e028125. [PMID: 36892072 DOI: 10.1161/JAHA.122.028125] [Reference Citation Analysis]
|
| 2 |
Tian X, Zhu L, Tian J, Wang S. Editorial: The role of epigenetic modification in MDSC differentiation and function. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1177138] [Reference Citation Analysis]
|
| 3 |
Tomela K, Pietrzak B, Galus Ł, Mackiewicz J, Schmidt M, Mackiewicz AA, Kaczmarek M. Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy. Cells 2023;12. [PMID: 36899926 DOI: 10.3390/cells12050789] [Reference Citation Analysis]
|
| 4 |
Zhao T, Liu S, Hanna NH, Jalal S, Ding X, Wan J, Yan C, Du H. LAL deficiency induced myeloid-derived suppressor cells as targets and biomarkers for lung cancer. J Immunother Cancer 2023;11. [PMID: 36914206 DOI: 10.1136/jitc-2022-006272] [Reference Citation Analysis]
|
| 5 |
Varela VA, da Silva Heinen LB, Marti LC, Caraciolo VB, Datoguia TS, Amano MT, Pereira WO. In vitro differentiation of myeloid suppressor cells (MDSC-like) from an immature myelomonocytic precursor THP-1. J Immunol Methods 2023;515:113441. [PMID: 36848984 DOI: 10.1016/j.jim.2023.113441] [Reference Citation Analysis]
|
| 6 |
Andrés CMC, Pérez de la Lastra JM, Juan CA, Plou FJ, Pérez-Lebeña E. Myeloid-Derived Suppressor Cells in Cancer and COVID-19 as Associated with Oxidative Stress. Vaccines (Basel) 2023;11. [PMID: 36851096 DOI: 10.3390/vaccines11020218] [Reference Citation Analysis]
|
| 7 |
Petrova V, Groth C, Bitsch R, Arkhypov I, Simon SCS, Hetjens S, Müller V, Utikal J, Umansky V. Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patients. Front Immunol 2023;14:1065767. [PMID: 36860876 DOI: 10.3389/fimmu.2023.1065767] [Reference Citation Analysis]
|
| 8 |
Pang B, Hu C, Li H, Nie X, Wang K, Zhou C, Yi H. Myeloidderived suppressor cells: Escorts at the maternal-fetal interface. Front Immunol 2023;14:1080391. [PMID: 36817414 DOI: 10.3389/fimmu.2023.1080391] [Reference Citation Analysis]
|
| 9 |
He J, Huo F, Tang H, Liu B, Bu L. Myeloid-derived suppressor cells in head and neck squamous cell carcinoma. International Review of Cell and Molecular Biology 2023. [DOI: 10.1016/bs.ircmb.2022.11.002] [Reference Citation Analysis]
|
| 10 |
Jiménez-Cortegana C, Galluzzi L. Myeloid-derived suppressor cells: Emerging players in cancer and beyond. Int Rev Cell Mol Biol 2023;375:xiii-xix. [PMID: 36967156 DOI: 10.1016/S1937-6448(23)00048-5] [Reference Citation Analysis]
|
| 11 |
Antuamwine BB, Bosnjakovic R, Hofmann-Vega F, Wang X, Theodosiou T, Iliopoulos I, Brandau S. N1 versus N2 and PMN-MDSC: A critical appraisal of current concepts on tumor-associated neutrophils and new directions for human oncology. Immunol Rev 2022. [PMID: 36504274 DOI: 10.1111/imr.13176] [Reference Citation Analysis]
|
| 12 |
Lee EJ, Jung S, Park KH, Park SI. Flow cytometry-based immunophenotyping of myeloid-derived suppressor cells in human breast cancer patient blood samples. J Immunol Methods 2022;510:113348. [PMID: 36058258 DOI: 10.1016/j.jim.2022.113348] [Reference Citation Analysis]
|
| 13 |
Rabold K, Zoodsma M, Grondman I, Kuijpers Y, Bremmers M, Jaeger M, Zhang B, Hobo W, Bonenkamp HJ, de Wilt JHW, Janssen MJR, Cornelissen LAM, van Engen-van Grunsven ICH, Mulder WJM, Smit JWA, Adema GJ, Netea MG, Li Y, Xu CJ, Netea-Maier RT. Reprogramming of myeloid cells and their progenitors in patients with non-medullary thyroid carcinoma. Nat Commun 2022;13:6149. [PMID: 36257966 DOI: 10.1038/s41467-022-33907-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Bizymi N, Matthaiou AM, Matheakakis A, Voulgari I, Aresti N, Zavitsanou K, Karasachinidis A, Mavroudi I, Pontikoglou C, Papadaki HA. New Perspectives on Myeloid-Derived Suppressor Cells and Their Emerging Role in Haematology. J Clin Med 2022;11:5326. [PMID: 36142973 DOI: 10.3390/jcm11185326] [Reference Citation Analysis]
|
| 15 |
Arkhypov I, Özbay Kurt FG, Bitsch R, Novak D, Petrova V, Lasser S, Hielscher T, Groth C, Lepper A, Hu X, Li W, Utikal J, Altevogt P, Umansky V. HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling. J Immunother Cancer 2022;10:e005551. [PMID: 36113897 DOI: 10.1136/jitc-2022-005551] [Reference Citation Analysis]
|
| 16 |
Al-mterin MA, Elkord E. Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets. Exploration of Targeted Anti-tumor Therapy 2022. [DOI: 10.37349/etat.2022.00097] [Reference Citation Analysis]
|
| 17 |
Xu Y, Yan J, Tao Y, Qian X, Zhang C, Yin L, Gu P, Liu Y, Pan Y, Tang R, Jiang W, Zhou R. Pituitary hormone α-MSH promotes tumor-induced myelopoiesis and immunosuppression. Science 2022;:eabj2674. [PMID: 35926007 DOI: 10.1126/science.abj2674] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
Zhang Z, Liu X, Chen D, Yu J. Radiotherapy combined with immunotherapy: the dawn of cancer treatment. Signal Transduct Target Ther 2022;7:258. [PMID: 35906199 DOI: 10.1038/s41392-022-01102-y] [Reference Citation Analysis]
|
| 19 |
Joshi S, Sharabi A. Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy. Pharmacology & Therapeutics 2022;235:108114. [DOI: 10.1016/j.pharmthera.2022.108114] [Reference Citation Analysis]
|
| 20 |
Li T, Bou-Dargham MJ, Fultang N, Li X, Pear WS, Sun H, Chen YH. c-Rel-dependent monocytes are potent immune suppressor cells in cancer. J Leukoc Biol 2022. [PMID: 35694784 DOI: 10.1002/JLB.1MA0422-518RR] [Reference Citation Analysis]
|
| 21 |
Deyhle MR, Callaway CS, Neyroud D, D'Lugos AC, Judge SM, Judge AR. Depleting Ly6G Positive Myeloid Cells Reduces Pancreatic Cancer-Induced Skeletal Muscle Atrophy. Cells 2022;11. [PMID: 35741022 DOI: 10.3390/cells11121893] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 22 |
Wang T, Denman D, Bacot SM, Feldman GM. Challenges and the Evolving Landscape of Assessing Blood-Based PD-L1 Expression as a Biomarker for Anti-PD-(L)1 Immunotherapy. Biomedicines 2022;10:1181. [DOI: 10.3390/biomedicines10051181] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 23 |
Perfilyeva YV, Ostapchuk YO, Tleulieva R, Kali A, Abdolla N, Krasnoshtanov VK, Perfilyeva AV, Belyaev NN. Myeloid-derived suppressor cells in COVID-19: A review. Clin Immunol 2022;238:109024. [PMID: 35489643 DOI: 10.1016/j.clim.2022.109024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 24 |
Alsalman A, Al-mterin MA, Elkord E, Dwivedi M. Role of T Regulatory Cells and Myeloid-Derived Suppressor Cells in COVID-19. Journal of Immunology Research 2022;2022:1-13. [DOI: 10.1155/2022/5545319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 25 |
Wu CF, Hung TT, Su YC, Chen PJ, Lai KH, Wang CC. Endoplasmic Reticulum Stress of Oral Squamous Cell Carcinoma Induces Immunosuppression of Neutrophils. Front Oncol 2022;12:818192. [PMID: 35372022 DOI: 10.3389/fonc.2022.818192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
Yang T, Qian Y, Liang X, Wu J, Zou M, Deng M. LILRB4, an immune checkpoint on myeloid cells. Blood Science 2022;4:49-56. [DOI: 10.1097/bs9.0000000000000109] [Reference Citation Analysis]
|
| 27 |
Schrijver IT, Karakike E, Théroude C, Baumgartner P, Harari A, Giamarellos-Bourboulis EJ, Calandra T, Roger T. High levels of monocytic myeloid-derived suppressor cells are associated with favorable outcome in patients with pneumonia and sepsis with multi-organ failure. Intensive Care Med Exp 2022;10:5. [PMID: 35146585 DOI: 10.1186/s40635-022-00431-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 28 |
Robinson A, Burgess M, Webb S, Louwe PA, Ouyang Z, Skola D, Han CZ, Batada NN, González-Huici V, Cassetta L, Glass CK, Jenkins SJ, Pollard JW. Systemic Influences of Mammary Cancer on Monocytes in Mice. Cancers (Basel) 2022;14:833. [PMID: 35159100 DOI: 10.3390/cancers14030833] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 29 |
Soler DC, Kerstetter-Fogle A, Young AB, Rayman P, Finke JH, Debanne SM, Cooper KD, Barnholtz-Sloan J, Sloan AE, McCormick TS. Healthy myeloid-derived suppressor cells express the surface ectoenzyme Vanin-2 (VNN2). Mol Immunol 2022;142:1-10. [PMID: 34953280 DOI: 10.1016/j.molimm.2021.12.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 30 |
Zilio S, Bicciato S, Weed D, Serafini P. CCR1 and CCR5 mediate cancer-induced myelopoiesis and differentiation of myeloid cells in the tumor. J Immunother Cancer 2022;10:e003131. [DOI: 10.1136/jitc-2021-003131] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 31 |
Tian S, Welte T, Mai J, Liu Y, Ramirez M, Shen H. Identification of an Aptamer With Binding Specificity to Tumor-Homing Myeloid-Derived Suppressor Cells. Front Pharmacol 2021;12:752934. [PMID: 35126104 DOI: 10.3389/fphar.2021.752934] [Reference Citation Analysis]
|
| 32 |
Malavika M, Sanju S, Poorna MR, Vishnu Priya V, Sidharthan N, Varma P, Mony U. Role of myeloid derived suppressor cells in sepsis. Int Immunopharmacol 2022;104:108452. [PMID: 34996010 DOI: 10.1016/j.intimp.2021.108452] [Reference Citation Analysis]
|
| 33 |
Shaul ME, Fridlender ZG. The dual role of neutrophils in cancer. Semin Immunol 2021;:101582. [PMID: 34974960 DOI: 10.1016/j.smim.2021.101582] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 34 |
Robinson A, Burgess M, Webb S, Louwe P, Ouyang Z, Skola D, Han C, Batada N, González-huici V, Cassetta L, Glass C, Jenkins S, Pollard J. Systemic influences of mammary cancer on monocytes in mice.. [DOI: 10.1101/2021.12.24.474104] [Reference Citation Analysis]
|
| 35 |
Singh B, Singh DK, Ganatra SR, Escobedo RA, Khader S, Schlesinger LS, Kaushal D, Mehra S. Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas. mBio 2021;12:e0318921. [PMID: 34903057 DOI: 10.1128/mbio.03189-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 36 |
Lin EC, Chen SW, Chen LK, Lin TA, Wu YX, Juan CC, Chang YI. Glucosamine Interferes With Myelopoiesis and Enhances the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells. Front Nutr 2021;8:762363. [PMID: 34901113 DOI: 10.3389/fnut.2021.762363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 37 |
Lin D, Shen L, Luo M, Zhang K, Li J, Yang Q, Zhu F, Zhou D, Zheng S, Chen Y, Zhou J. Circulating tumor cells: biology and clinical significance. Signal Transduct Target Ther 2021;6:404. [PMID: 34803167 DOI: 10.1038/s41392-021-00817-8] [Cited by in Crossref: 37] [Cited by in F6Publishing: 47] [Article Influence: 18.5] [Reference Citation Analysis]
|
| 38 |
Muñoz R, Girotti A, Hileeto D, Arias FJ. Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment. Cancers (Basel) 2021;13:5414. [PMID: 34771577 DOI: 10.3390/cancers13215414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 39 |
Siemińska I, Węglarczyk K, Surmiak M, Kurowska-Baran D, Sanak M, Siedlar M, Baran J. Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions. Front Immunol 2021;12:748097. [PMID: 34659245 DOI: 10.3389/fimmu.2021.748097] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 40 |
Sharma V, Sachdeva N, Gupta V, Nada R, Jacob J, Sahni D, Aggarwal A. IL‐6 is associated with expansion of myeloid‐derived suppressor cells and enhanced immunosuppression in pancreatic adenocarcinoma patients. Scand J Immunol 2021;94. [DOI: 10.1111/sji.13107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 41 |
Sindhi R, Ashokkumar C, Singh V, Spishock B, Saunders M, Mabasa A, Sindhi E, Sethi P, Reddy A, Subramaniam S, Nibhanupudy B. Cellular and Antibody Immunity after COVID-19 Vaccination at >4-Month Follow Up in Immunocompetent and Immunocompromised Subjects.. [DOI: 10.1101/2021.10.07.21257459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 42 |
Li K, Shi H, Zhang B, Ou X, Ma Q, Chen Y, Shu P, Li D, Wang Y. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct Target Ther 2021;6:362. [PMID: 34620838 DOI: 10.1038/s41392-021-00670-9] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 32.0] [Reference Citation Analysis]
|
| 43 |
Nomani M, Varahram M, Tabarsi P, Hashemian SM, Jamaati H, Malekmohammad M, Ghazi M, Adcock IM, Mortaz E. Decreased neutrophil-mediated bacterial killing in COVID-19 patients. Scand J Immunol 2021;94:e13083. [PMID: 35993347 DOI: 10.1111/sji.13083] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 44 |
Gassmann H, Schneider K, Evdokimova V, Ruzanov P, Schober SJ, Xue B, von Heyking K, Thiede M, Richter GHS, Pfaffl MW, Noessner E, Stein LD, Sorensen PH, Burdach SEG, Thiel U. Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and Function. Cells 2021;10:2081. [PMID: 34440851 DOI: 10.3390/cells10082081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 45 |
Vanhaver C, van der Bruggen P, Bruger AM. MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer. J Clin Med 2021;10:2872. [PMID: 34203451 DOI: 10.3390/jcm10132872] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 46 |
Tolle F, Umansky V, Utikal J, Kreis S, Bréchard S. Neutrophils in Tumorigenesis: Missing Targets for Successful Next Generation Cancer Therapies? Int J Mol Sci 2021;22:6744. [PMID: 34201758 DOI: 10.3390/ijms22136744] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 47 |
Ge Y, Cheng D, Jia Q, Xiong H, Zhang J. Mechanisms Underlying the Role of Myeloid-Derived Suppressor Cells in Clinical Diseases: Good or Bad. Immune Netw 2021;21:e21. [PMID: 34277111 DOI: 10.4110/in.2021.21.e21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 48 |
Güç E, Pollard JW. Redefining macrophage and neutrophil biology in the metastatic cascade. Immunity 2021;54:885-902. [PMID: 33979586 DOI: 10.1016/j.immuni.2021.03.022] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 17.5] [Reference Citation Analysis]
|
| 49 |
Coudereau R, Waeckel L, Cour M, Rimmele T, Pescarmona R, Fabri A, Jallades L, Yonis H, Gossez M, Lukaszewicz AC, Argaud L, Venet F, Monneret G; he RICO study group. Emergence of immunosuppressive LOX-1+ PMN-MDSC in septic shock and severe COVID-19 patients with acute respiratory distress syndrome. J Leukoc Biol 2021. [PMID: 33909917 DOI: 10.1002/JLB.4COVBCR0321-129R] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 50 |
Jin ZL, Gao WY, Liao SJ, Yu T, Shi Q, Yu SZ, Cai YF. Paeonol inhibits the progression of intracerebral haemorrhage by mediating the HOTAIR/UPF1/ACSL4 axis. ASN Neuro 2021;13:17590914211010647. [PMID: 33906483 DOI: 10.1177/17590914211010647] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 51 |
Siemińska I, Poljańska E, Baran J. Granulocytes and Cells of Granulocyte Origin-The Relevant Players in Colorectal Cancer. Int J Mol Sci 2021;22:3801. [PMID: 33917620 DOI: 10.3390/ijms22073801] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 52 |
Lutz MB, Eckert IN. Comments on the ambiguity of selected surface markers, signaling pathways and omics profiles hampering the identification of myeloid-derived suppressor cells. Cell Immunol 2021;364:104347. [PMID: 33838447 DOI: 10.1016/j.cellimm.2021.104347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 53 |
Falck-Jones S, Vangeti S, Yu M, Falck-Jones R, Cagigi A, Badolati I, Österberg B, Lautenbach MJ, Åhlberg E, Lin A, Lepzien R, Szurgot I, Lenart K, Hellgren F, Maecker H, Sälde J, Albert J, Johansson N, Bell M, Loré K, Färnert A, Smed-Sörensen A. Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity. J Clin Invest 2021;131:144734. [PMID: 33492309 DOI: 10.1172/JCI144734] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 30.0] [Reference Citation Analysis]
|
| 54 |
Liu P, Peng C, Chen X, Wu L, Yin M, Li J, Qin Q, Kuang Y, Zhu W. Acitretin Promotes the Differentiation of Myeloid-Derived Suppressor Cells in the Treatment of Psoriasis. Front Med (Lausanne) 2021;8:625130. [PMID: 33834031 DOI: 10.3389/fmed.2021.625130] [Reference Citation Analysis]
|
| 55 |
Suszczyk D, Skiba W, Jakubowicz-Gil J, Kotarski J, Wertel I. The Role of Myeloid-Derived Suppressor Cells (MDSCs) in the Development and/or Progression of Endometriosis-State of the Art. Cells 2021;10:677. [PMID: 33803806 DOI: 10.3390/cells10030677] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 56 |
Caronni N, Montaldo E, Mezzanzanica L, Cilenti F, Genua M, Ostuni R. Determinants, mechanisms, and functional outcomes of myeloid cell diversity in cancer. Immunol Rev 2021;300:220-36. [PMID: 33565148 DOI: 10.1111/imr.12944] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 57 |
Kho VM, Mekers VE, Span PN, Bussink J, Adema GJ. Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment. Cell Immunol 2021;362:104298. [PMID: 33592541 DOI: 10.1016/j.cellimm.2021.104298] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 58 |
Pawelec G, Picard E, Bueno V, Verschoor CP, Ostrand-Rosenberg S. MDSCs, ageing and inflammageing. Cell Immunol 2021;362:104297. [PMID: 33550187 DOI: 10.1016/j.cellimm.2021.104297] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 59 |
Fultang N, Li X, Li T, Chen YH. Myeloid-Derived Suppressor Cell Differentiation in Cancer: Transcriptional Regulators and Enhanceosome-Mediated Mechanisms. Front Immunol 2020;11:619253. [PMID: 33519825 DOI: 10.3389/fimmu.2020.619253] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 60 |
Robinson A, Han CZ, Glass CK, Pollard JW. Monocyte Regulation in Homeostasis and Malignancy. Trends Immunol 2021;42:104-19. [PMID: 33446416 DOI: 10.1016/j.it.2020.12.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 61 |
Domagala M, Laplagne C, Leveque E, Laurent C, Fournié JJ, Espinosa E, Poupot M. Cancer Cells Resistance Shaping by Tumor Infiltrating Myeloid Cells. Cancers (Basel) 2021;13:E165. [PMID: 33418996 DOI: 10.3390/cancers13020165] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 62 |
Muefong CN, Owolabi O, Donkor S, Charalambous S, Mendy J, Sey ICM, Bakuli A, Rachow A, Geldmacher C, Sutherland JS. Major Neutrophil-Derived Soluble Mediators Associate With Baseline Lung Pathology and Post-Treatment Recovery in Tuberculosis Patients. Front Immunol 2021;12:740933. [PMID: 34887853 DOI: 10.3389/fimmu.2021.740933] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 63 |
Abrams SI. Developmental pathways of myeloid-derived suppressor cells in neoplasia. Cell Immunol 2021;360:104261. [PMID: 33373817 DOI: 10.1016/j.cellimm.2020.104261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
